Ohio Public Employees Retirement System (OPERS)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.9K Buy
2,062
+87
+4% +$1.17K ﹤0.01% 2102
2025
Q4
$22.2K Buy
1,975
+179
+10% +$2.05K ﹤0.01% 2184
2025
Q3
$20.8K Buy
1,796
+336
+23% +$3.94K ﹤0.01% 2187
2025
Q2
$17.9K Buy
1,460
+203
+16% +$2.55K ﹤0.01% 2214
2025
Q1
$18K Sell
1,257
-61,060
-98% -$953K ﹤0.01% 2200
2024
Q4
$992K Sell
62,317
-23,806
-28% -$471K ﹤0.01% 1354
2024
Q3
$2.07M Buy
86,123
+28
+0% +$640 0.01% 1046
2024
Q2
$1.72M Sell
86,095
-27,280
-24% -$531K 0.01% 1035
2024
Q1
$2.26M Sell
113,375
-26,371
-19% -$510K 0.01% 930
2023
Q4
$3.13M Buy
139,746
+13,538
+11% +$279K 0.01% 839
2023
Q3
$2.55M Buy
126,208
+21,255
+20% +$482K 0.01% 867
2023
Q2
$2.68M Buy
104,953
+40,910
+64% +$1.08M 0.01% 894
2023
Q1
$1.91M Sell
64,043
-35,458
-36% -$1.03M 0.01% 1009
2022
Q4
$2.69M Buy
99,501
+13,919
+16% +$340K 0.01% 889
2022
Q3
$1.86M Buy
85,582
+11,164
+15% +$292K 0.01% 1047
2022
Q2
$2.04M Sell
74,418
-1,707
-2% -$49K 0.01% 1059
2022
Q1
$2.55M Buy
76,125
+178
+0.2% +$5.73K 0.01% 1030
2021
Q4
$2.63M Buy
75,947
+10,191
+15% +$329K 0.01% 1019
2021
Q3
$2.05M Buy
65,756
+64,341
+4,547% +$2.18M 0.01% 1109
2021
Q2
$51K Buy
1,415
+52
+4% +$2.15K ﹤0.01% 1886
2021
Q1
$60K Sell
1,363
-69
-5% -$3.24K ﹤0.01% 1833
2020
Q4
$66K Sell
1,432
-138
-9% -$5.74K ﹤0.01% 1728
2020
Q3
$52K Sell
1,570
-86
-5% -$2.75K ﹤0.01% 1694
2020
Q2
$49K Sell
1,656
-88
-5% -$2.55K ﹤0.01% 1709
2020
Q1
$47K Buy
1,744
+131
+8% +$3.91K ﹤0.01% 1618
2019
Q4
$54K Sell
1,613
-98
-6% -$3.55K ﹤0.01% 1730
2019
Q3
$64K Buy
1,711
+51
+3% +$1.95K ﹤0.01% 1763
2019
Q2
$72K Sell
1,660
-169
-9% -$7.23K ﹤0.01% 1715
2019
Q1
$78K Sell
1,829
-224
-11% -$10K ﹤0.01% 1690
2018
Q4
$92K Sell
2,053
-103
-5% -$5.4K ﹤0.01% 1522
2018
Q3
$148K Sell
2,156
-216
-9% -$13.9K ﹤0.01% 1546
2018
Q2
$136K Sell
2,372
-33,236
-93% -$1.76M ﹤0.01% 1570
2018
Q1
$1.64M Buy
35,608
+10,237
+40% +$486K 0.01% 1091
2017
Q4
$1.17M Buy
25,371
+43
+0.2% +$1.98K 0.01% 1230
2017
Q3
$1.14M Buy
25,328
+19,984
+374% +$853K 0.01% 1209
2017
Q2
$210K Sell
5,344
-296
-5% -$11.2K ﹤0.01% 1476
2017
Q1
$215K Sell
5,640
-556
-9% -$21.7K ﹤0.01% 1459
2016
Q4
$257K Sell
6,196
-273
-4% -$9.76K ﹤0.01% 1438
2016
Q3
$224K Sell
6,469
-287
-4% -$10.1K ﹤0.01% 1450
2016
Q2
$220K Buy
6,756
+543
+9% +$16.6K ﹤0.01% 1366
2016
Q1
$178K Buy
6,213
+1,714
+38% +$45.7K ﹤0.01% 1389
2015
Q4
$150K Buy
4,499
+898
+25% +$27.9K ﹤0.01% 1437
2015
Q3
$102K Buy
3,601
+1,948
+118% +$68K ﹤0.01% 1621
2015
Q2
$67K Sell
1,653
-31,984
-95% -$1.44M ﹤0.01% 1697
2015
Q1
$1.66M Sell
33,637
-21,990
-40% -$1.02M 0.01% 1019
2014
Q4
$2.53M Buy
+55,627
New +$2.19M 0.01% 806

Other funds holding AVNS

Ohio Public Employees Retirement System (OPERS)'s AVNS Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Avanos Medical (AVNS) stake by 4.4% in Q1 2026, buying an estimated $1.17K and bringing the position to 2,062 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Ohio Public Employees Retirement System (OPERS) first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.13M in Q4 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 2,062 shares of Avanos Medical worth $28.9K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 87 Avanos Medical shares in Q1 2026, an estimated $1.17K.
  • Avanos Medical made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #2102 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Avanos Medical position peaked at $3.13M in Q4 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.